Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-02-013568
Filing Date
2002-11-07
Accepted
2002-11-07 14:24:52
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K d00935a2e10vkza.htm 10-K/A 1014174
3 EX-23.1 CONSENT DELOITTE & TOUCHE LLP d00935a2exv23w1.txt EX-23.1 798
4 EX-23.2 CONSENT OF KPMG d00935a2exv23w2.txt EX-23.2 954
5 EX-99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d00935a2exv99w1.txt EX-99.1 1338
6 EX-99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER d00935a2exv99w2.txt EX-99.2 1255
  Complete submission text file 0000950134-02-013568.txt   1020709
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-18231 | Film No.: 02812370
SIC: 2834 Pharmaceutical Preparations